Veterinary Skin Substitute Matrices Market Report 2026

The veterinary skin substitute matrices market size has grown rapidly in recent years. It will grow from $1.21 billion in 2025 to $1.37 billion in 2026 at a compound annual growth rate (CAGR) of 13.2%. The growth in the historic period can be attributed to rising incidence of traumatic injuries in animals, increasing number of veterinary surgical procedures, limited availability of donor skin grafts in veterinary care, growing awareness of advanced wound healing solutions, expansion of veterinary dermatology practices.

The veterinary skin substitute matrices market size is expected to see rapid growth in the next few years. It will grow to $2.27 billion by 2030 at a compound annual growth rate (CAGR) of 13.4%. The growth in the forecast period can be attributed to advancements in bioengineered tissue regeneration technologies, increasing adoption of precision veterinary regenerative medicine, rising demand for cost-effective chronic wound management solutions, growth in companion animal healthcare expenditure, development of next-generation bioactive scaffold materials. Major trends in the forecast period include increasing adoption of bioengineered collagen-based skin matrices for advanced veterinary wound healing, growing use of hydrogel-based regenerative scaffolds for chronic animal wound management, expansion of combination biomaterial matrices integrating growth factors for accelerated tissue regeneration, rising demand for minimally invasive skin graft substitutes in veterinary surgical procedures, increasing application of biodegradable synthetic matrices for improved post-operative healing outcomes in animals.

The rising pet adoption is expected to propel the growth of the veterinary skin substitute matrices market going forward. Pet adoption refers to the process of assuming responsibility for a pet by offering it a permanent home, care, and companionship. The increase in pet adoption is driven by growing awareness of animal welfare, as it offers companionship, supports emotional well-being, and helps decrease stray animal populations. Veterinary skin substitute matrices support pet adoption by enhancing the healing process of injured or rescued animals, ensuring quicker recovery and better health, which improves their chances of finding caring homes. For instance, in February 2026, according to the American Society for the Prevention of Cruelty to Animals, a US-based nonprofit organization dedicated to preventing cruelty to animals, total animal adoptions across the US reached 4.2 million animals in 2025, representing a 0.7% increase from 2024. Therefore, the rising pet adoption is driving the growth of the veterinary skin substitute matrices market.

Leading companies operating in the veterinary skin substitute matrices market are focusing on developing and expanding access to advanced wound care and skin support solutions for animals to improve healing outcomes, shorten healing time, and enhance patient comfort. Veterinary skin substitute matrices refer to engineered biological or synthetic materials utilized in wound management that replicate the skin’s extracellular matrix, supporting tissue regeneration, cellular migration, and effective healing in dermatological conditions and surgical sites. For instance, in July 2024, KeraVet Bio, a US-based veterinary wound care company, expanded the nationwide distribution of its flagship keratin-based wound management product, KeraVet Gel, through all major veterinary product distributors, including Covetrus, Patterson Veterinary, Victor Medical Company, MWI Animal Health, and Midwest Veterinary Supply. The prescription-only hydrogel utilizes IP-protected keratin technology and an effective bitterant to support improved and faster wound healing for dogs and cats while minimizing self-trauma behaviors such as licking, simplifying wound care, and reducing the need for restraint devices such as E-collars across veterinary practices nationwide.

In May 2025, NovaBone Products LLC, a US-based developer and manufacturer of advanced bioactive glass bone graft substitutes, partnered with Summit Products Group. Through this partnership, NovaBone aims to broaden the distribution of NovaForm Wound Matrix in the U. S., offering veterinarians advanced synthetic skin substitute solutions that support wound healing and tissue regeneration in animals. Summit Products Group is a US-based provider of advanced surgical and regenerative wound care solutions, primarily specializing in collagen-based and bioengineered matrices.

Major companies operating in the veterinary skin substitute matrices market are Medtronic plc, Stryker Corporation, Zimmer Biomet Holdings Inc., Smith & Nephew plc, Coloplast A/S, Arthrex Vet Systems Inc., Integra LifeSciences Holdings Corporation, Organogenesis Holdings Inc., Aetna Inc., LifeCell Corporation a subsidiary of AbbVie Inc., Aroa Biosurgery Ltd., PolyNovo Biomaterials Pty Ltd., Merck Animal Health, Tissue Regenix Group plc, Imbed Biosciences Inc., MedSkin Solutions Dr. Suwelack AG, Vetrix LLC, Cook Animal Health a division of Cook Medical LLC, HiFarmaX Inc., Equine Amnio Solutions LLC, Royal Biologics Inc., VetStem Biopharma Inc., CelluHeal Inc.

North America was the largest region in the veterinary skin substitute matrices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary skin substitute matrices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the veterinary skin substitute matrices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The veterinary skin substitute matrices market consists of sales of bi-layered skin substitutes, nanofiber mats, and bioactive wound dressings. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.